Evidence map›Paper›PMID 21519805›Full record

ArticleInternational journal of colorectal disease2011

Interaction between CTLA4 gene and IBD5 locus in Hungarian Crohn's disease patients.

Veronika Csöngei, Luca Járomi, Eniko Sáfrány, Csilla Sipeky, Lili Magyari, Noémi Polgár, Judit Bene, Patrícia Sarlós, Lilla Lakner, Eszter Baricza and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of colorectal disease, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Veronika CsöngeiDepartment of Medical Genetics, University of Pécs, Pécs, Szigeti út 12, H-7624, Hungary.
Luca Járomi
Eniko Sáfrány
Csilla Sipeky
Lili Magyari
Noémi Polgár
Judit Bene
Patrícia Sarlós
Lilla Lakner
Eszter Baricza
Melinda Szabó
Gábor Rappai
Béla Melegh
University of Pecs · HUMarkusovszky Egyetemi Oktatókórház · HURobert Koch Institute · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUNDS AND

aimsThe IGR2198a_1 and IGR2096a_1 variants of the IBD5 region were found to be associated with Crohn's disease (CD) in the Hungarian population, while IGR2230a_1 does not seem to confer risk for the disease. In the present study, our aim was to investigate the statistical interaction of these three IBD5 polymorphisms with the +49 A/G substitution within the cytotoxic T lymphocyte antigen-4 (CTLA4) gene, detected previously as neutral gene variant in Hungarian IBD patients.

methodsA total of 305 unrelated subjects with CD and 310 healthy controls were genotyped with PCR-RFLP methods.

resultsIn contrast with single gene effects, after genotype stratification, the IGR2198a_1 C and IGR2096a_1 T variants were found to confer susceptibility only in subjects with CTLA4 +49 AA genotype (P = 0.008; OR = 1.86 and P = 0.016; OR = 1.74, respectively), for IGR2230a_1 no such effect on disease risk could be demonstrated.

conclusionAnalysis of specific genotype combinations unfolded a possible association between the CTLA4 +49 A/G substitution and two of the observed IBD5 variants with respect to disease risk.

Indexed as

Epistasis, GeneticGenetic Predisposition to DiseaseAdultCase-Control StudiesCrohn DiseaseCTLA-4 AntigenFemaleGene FrequencyGenetic LociHumansHungaryMaleRisk FactorsCTLA-4 AntigenCTLA4 protein, human

Identifiers

PMID21519805
OpenAlexW2022274471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.